Liver fibrosis index-based nomograms for identifying esophageal varices in patients with chronic hepatitis B related cirrhosis

被引:5
|
作者
Xu, Shi-Hao [1 ,2 ]
Wu, Fang [3 ]
Guo, Le-Hang [1 ]
Zhang, Wei-Bing [1 ]
Xu, Hui-Xiong [1 ]
机构
[1] Nanjing Med Univ, Shanghai Peoples Hosp 10, Dept Med Ultrasound, 301 Yanchang Middle Rd, Shanghai 200072, Peoples R China
[2] Wenzhou Med Univ, Dept Ultrasonog, Affiliated Hosp 1, Wenzhou 325000, Zhejiang, Peoples R China
[3] Wenzhou Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Wenzhou 325000, Zhejiang, Peoples R China
关键词
Real-time tissue elastography; Chronic hepatitis B; Cirrhosis; Esophageal varices; Nomogram; Decision curve analysis; TIME TISSUE ELASTOGRAPHY; COUNT/SPLEEN DIAMETER RATIO; NONINVASIVE ASSESSMENT; GASTROESOPHAGEAL VARICES; TRANSIENT ELASTOGRAPHY; PORTAL-HYPERTENSION; PLATELET COUNT; KINGS SCORE; RISK; PREDICTION;
D O I
10.3748/wjg.v26.i45.7204
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND Esophageal varices (EV) are the most fatal complication of chronic hepatitis B (CHB) related cirrhosis. The prognosis is poor, especially after the first upper gastrointestinal hemorrhage. AIM To construct nomograms to predict the risk and severity of EV in patients with CHB related cirrhosis. METHODS Between 2016 and 2018, the patients with CHB related cirrhosis were recruited and divided into a training or validation cohort at The First Affiliated Hospital of Wenzhou Medical University. Clinical and ultrasonic parameters that were closely related to EV risk and severity were screened out by univariate and multivariate logistic regression analyses, and integrated into two nomograms, respectively. Both nomograms were internally and externally validated by calibration, concordance index (C-index), receiver operating characteristic curve, and decision curve analyses (DCA). RESULTS A total of 307 patients with CHB related cirrhosis were recruited. The independent risk factors for EV included Child-Pugh class [odds ratio (OR) = 7.705, 95% confidence interval (CI) = 2.169-27.370, P = 0.002], platelet count (OR = 0.992, 95%CI = 0.984-1.000, P = 0.044), splenic portal index (SPI) (OR = 3.895, 95%CI = 1.630-9.308, P = 0.002), and liver fibrosis index (LFI) (OR = 3.603, 95%CI = 1.336-9.719, P = 0.011); those of EV severity included Child-Pugh class (OR = 5.436, 95%CI = 2.112-13.990, P < 0.001), mean portal vein velocity (OR = 1.479, 95%CI = 1.043-2.098, P = 0.028), portal vein diameter (OR = 1.397, 95%CI = 1.021-1.912, P = 0.037), SPI (OR = 1.463, 95%CI = 1.030-2.079, P = 0.034), and LFI (OR = 3.089, 95%CI = 1.442-6.617, P = 0.004). Two nomograms (predicting EV risk and severity, respectively) were well-calibrated and had a favorable discriminative ability, with C-indexes of 0.916 and 0.846 in the training cohort, respectively, higher than those of other predictive indexes, like LFI (C-indexes = 0.781 and 0.738), SPI (C-indexes = 0.805 and 0.714), ratio of platelet count to spleen diameter (PSR) (C-indexes = 0.822 and 0.726), King's score (C-indexes = 0.694 and 0.609), and Lok index (C-indexes = 0.788 and 0.700). The areas under the curves (AUCs) of the two nomograms were 0.916 and 0.846 in the training cohort, respectively, higher than those of LFI (AUCs = 0.781 and 0.738), SPI (AUCs = 0.805 and 0.714), PSR (AUCs = 0.822 and 0.726), King's score (AUCs = 0.694 and 0.609), and Lok index (AUCs = 0.788 and 0.700). Better net benefits were shown in the DCA. The results were validated in the validation cohort. CONCLUSION Nomograms incorporating clinical and ultrasonic variables are efficient in noninvasively predicting the risk and severity of EV.
引用
收藏
页码:7204 / 7221
页数:18
相关论文
共 50 条
  • [41] Regression of esophageal varices and splenomegaly in two patients with hepatitis-C-related liver cirrhosis after interferon and ribavirin combination therapy
    Lee, Soon Jae
    Cho, Yoo-Kyung
    Na, Soo-Young
    Choi, Eun Kwang
    Boo, Sun Jin
    Jeong, Seung Uk
    Song, Hyung Joo
    Kim, Heung Up
    Kim, Bong Soo
    Song, Byung-Cheol
    CLINICAL AND MOLECULAR HEPATOLOGY, 2016, 22 (03) : 390 - 395
  • [42] Noninvasive assessment of liver fibrosis in patients with chronic hepatitis B
    Masaru Enomoto
    Hiroyasu Morikawa
    Akihiro Tamori
    Norifumi Kawada
    World Journal of Gastroenterology, 2014, (34) : 12031 - 12038
  • [43] Effects of heparin on liver fibrosis in patients with chronic hepatitis B
    Jun Shi Jing-Hua Hao Wan-Hua Ren Ju-Ren Zhu
    World Journal of Gastroenterology, 2003, 9 (07) : 1611 - 1614
  • [44] Noninvasive assessment of liver fibrosis in patients with chronic hepatitis B
    Enomoto, Masaru
    Morikawa, Hiroyasu
    Tamori, Akihiro
    Kawada, Norifumi
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (34) : 12031 - 12038
  • [45] Effects of heparin on liver fibrosis in patients with chronic hepatitis B
    Shi, J
    Hao, JH
    Ren, WH
    Zhu, JR
    WORLD JOURNAL OF GASTROENTEROLOGY, 2003, 9 (07) : 1611 - 1614
  • [46] Non-invasive tests for assessing liver fibrosis and cirrhosis in chronic hepatitis B
    Huang, Rui
    Wu, Chao
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2025, 10 (04): : 280 - 282
  • [47] Predictive model for fibrosis and cirrhosis in chronic hepatitis B using liver stiffness measurement
    Fung, James
    Lai, Ching Lung
    Fong, Daniel
    Yuen, John
    Wong, Danny
    Yuen, Man-Fung
    HEPATOLOGY, 2007, 46 (04) : 651A - 652A
  • [48] Depression in patients with chronic hepatitis B and cirrhosis is closely associated with the severity of liver cirrhosis
    Zhu, Hai-Peng
    Gu, Yu-Rong
    Zhang, Geng-Lin
    Su, Yu-Jie
    Wang, Ke
    Zheng, Yu-Bao
    Gao, Zhi-Liang
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 12 (01) : 405 - 409
  • [49] Identification and validation of plasma AGRN as a novel diagnostic biomarker of hepatitis B Virus-related chronic hepatitis and liver fibrosis/cirrhosis
    Ai, Rong
    Li, Lu
    Yuan, Xiwei
    Zhao, Dandan
    Miao, Tongguo
    Guan, Weiwei
    Dong, Shiming
    Dong, Chen
    Dou, Yao
    Hou, Mengmeng
    Nan, Yuemin
    HISTOLOGY AND HISTOPATHOLOGY, 2024, 39 (08) : 1025 - 1035
  • [50] Liver stiffness measurement in patients with chronic hepatitis B is not as useful as that in patients with chronic hepatitis C for the assessment of liver fibrosis
    Seo, Yeon Seok
    Kim, Eun Sun
    Kwon, Yong Dae
    Park, Sanghun
    Keum, Bora
    Park, Beom Jin
    Kim, Yong Sik
    Jeen, Yoon Tae
    Chun, Hoon Jai
    Kim, Chang Duck
    Ryu, Ho Sang
    Um, Soon Ho
    HEPATOLOGY, 2007, 46 (04) : 842A - 842A